Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin

Molecular Carcinogenesis

Volumn 17, Issue 2, 1996, Pages 62-69

  Rho, Okkyung ^a   Bol, David K ^a   You, Jinsong ^a   Beitrán, Linda ^a   Rupp, Tim ^a   Digiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemical carcinogenesis; Keratinocyte proliferation; Papilloma; Paracrine stimulation; Squamous cell carcinoma

Indexed keywords

SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOMA, SQUAMOUS CELL; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; INSULIN-LIKE GROWTH FACTOR I; KERATINOCYTES; MICE; PAPILLOMA; POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

ANIMALIA;

EID: 0029851189     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199610)17:2<62::AID-MC2>3.0.CO;2-V     Document Type: Article

References (45)

1. Aaronson SA. Growth factors and cancer. Science 254:1146- 1153,1991.
2. Derynck R, Goeddel DV, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factors α and β and the epidermal growth factor receptor by human tumors. Cancer Res 47:707-712,1987.
3. Wang XJ, Green DA, Eckhardt JN, Rothnagel JA, Roop DR. Epidermal expression of transforming growth factor-α in transgenic mice: Induction of spontaneous and TPA-induced papillomas via a mechanism independent of Ha-ras activation of overexpression. Mol Carcinog 10:15-22,1994.
4. Humbel RE. Insulin-like growth factors I and II. Eur J Biochem 190:445-462,1990.
5. Ristow HJ, Messmer TO. Basic fibroblast growth factor and insulin-like growth factor I are strong mitogens for cultured mouse keratinocytes. J Cell Physiol 137:707-712,1988.
6. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin- like growth factors. Annu Rev Physiol 47:443-467,1985.
7. Hill DJ. Stimulation of cartilage zones of the calf costochondral growth plate in vitro by growth hormone dependent rat plasma somatomedin activity. J Endocrinol 83:219-227,1979.
8. Schmid C, Steiner T, Froesch ER. Preferential enhancement of myoblast differentiation by insulin-like growth factors (IGF-I and IGF-II) in primary cultures of chicken embryonic cells. FEBS Lett 161:117-121,1983.
9. Schmid C, Steiner T, Froesch ER. Insulin-like growth factor I supports differentiation of cultured osteoblast-like cells. FEBS Lett 173:48-52,1984.
10. Van Wyk JJ. Hormonal Proteins and Peptides. Vol. XII. Academic Press, New York,1984, pp. 81-125.
11. Kurtz A, Jelkmann W, Bauer C. A new candidate for the regulation of erythropoiesis. Insulin-like growth factor I. FEBS Lett 149:105-108,1982.
12. Bichell DP, Kikuchi K, Rotwein P. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol Endocrinol 6:1899-1908,1992.
13. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA 83:9343-9347,1986.
14. Rotwein P, Bochell DP, Kikuchi K. Multifunctional regulation of IGF-I gene expression. Mol Reprod Dev 35:358-364,1993.
15. Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 5:3-18,1991.
16. Jansen E, Steenbergh PH, Van Schaik FMA, Sussenbach JS. The human IGF-I gene contains two cell type-specifically regulated promotors. Biochem Biophys Res Commun 1187:1219- 1226,1992.
17. Soos MA, Field CE, Siddle K. Purified hybrid insulin/insulin-like growth factor-1 receptors bind insulin-like growth factor-l, but not insulin, with high affinity. Biochem J 290:419-426,1993.
18. Barreca A, DeLuca M, Del Monte P, et al. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 151:262-268,1992.
19. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-I) and type IIGF receptor (IGF-Ir). Cell 75:59- 72,1993.
20. Chen SC, Chou CK, Wong FH, Chang CM, Hu CP. Overexpression of epidermal growth factor and insulin-like growth factor-l receptors and autocrine stimulation in human esophageal carcinoma cells. Cancer Res 51:1898-1903,1991.
21. Stewart AJ, Johnson MD, May FEB, Westley BR. Role of insulin- like growth factors and the type I insulin-like growth factor receptors in estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178,1990.
22. Kaleko M, Rutter W, Miller AD. Overexpression of the human insulin like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 10:464-473,1990.
23. Sell C, Dumenil G, Deveaud C, et al. Effect of a null mutation of the insulin-like growth factor I receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612,1994.
24. Rho O, Beltrán LM, Gimenez-Conti IB, DiGiovanni J. Altered expression of the epidermal growth factor and transforming growth factor-α during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11:19-28,1994.
25. DiGiovanni J, Boutwell RK. Tumor promoting activity of 1,8- dihydroxy-3-methyl-9-anthrone (chrysarobin) in female SENCAR mice. Carcinogenesis 4:281-284,1983.
26. Balmain A, Krumlauf R, Vass JK, Birnie GD. Cloning and characterization of the abundant cytoplasmic 7S RNA from mouse cells. Nucleic Acids Res 10:4259-4277,1982.
27. DiGiovanni J, Miller DR, Singer JM, Viaje A, Slaga TJ. Benzo(a)pyrene metabolism in primary cultures of mouse epidermal cells and untransformed and transformed epidermal cell lines. Cancer Res 42:2579-2586,1982.
28. Fusenig NE, Breitkreutz D, Dzarlieva RT, Boukamp P, Bohnert A, Tigen T. Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J Invest Dermatol 81:168-175,1983.
29. Yuspa SH, Morgan DL. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis. Nature 293:72-74,1981.
30. Ruggeri B, Caamano J, Goodrow T, et al. Alterations of the p53 tumor suppressor gene during mouse skin tumor progression. Cancer Res 51:6615-6621,1991.
31. Chomczynski D, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159,1987.
32. Aurray C, Rougeon F. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107:303-314,1980.
33. Bell GI, Stempien MM, Fong NM, Rall LB. Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors. Nucleic Acids Res 14:7873-7882,1986.
34. Wada J, Liu ZZ, Alvares K, et al. Cloning of cDNA for the alpha subunit of mouse insulin-like growth factor I receptor and the role of the receptor in metanephric development. Proc Natl Acad Sci USA 90:10360-10364,1993.
35. Brown K, Bailleul B, Ramsden M. Isolation and characterization of the 5′ flanking region of the mouse c-Ha-ras gene. Mol Carcinog 1:161-170,1988.
36. Kiguchi K, Beltrán LM, You J, Rho O, DiGiovanni J. Elevation of transforming growth factor-α mRNA and protein expression by diverse tumor promoters in SENCAR mouse epidermis. Mol Carcinog 12:225-235,1995.
37. Tavakkol A, Elder JT, Griffiths CEM, et al. Expression of growth hormone receptor, IGF-I and IGF-I receptor mRNA and proteins in human skin. J Invest Dermatol 99:343-349,1992.
38. Tricoli JV, Rall LB, Karakousis CP, et al. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas. Cancer Res 46:6169-6173,1986.
39. Tennenbaum T, Belanger AJ, Click AB, Tamura R, Quaranta V, Yuspa SH. A splice variant of α6 integrin is associated with malignant conversion in mouse skin tumorigenesis. Proc Natl Acad Sci USA 92:7041-7045,1995.
40. Salmi M, Gron-Virta K, Sointu P, Grenman R, Kilimo H, Halkanen S. Regulated expression of exon v6 containing isoforms of CD44 in man: Downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122:431-442,1993.
41. Yee D, Paik S, Lebovic GS, et al. Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer. Mol Endocrinol 3:509-517,1989.
42. Mathews LS, Hammer RE, Behringer RR, et al. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology 123:2827-2833,1988.
43. Guler HP, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85:4889-4893,1988.
44. Sell C, Baserga R, Rubin R. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis. Cancer Res 55:303-306,1995.
45. Bol DK, Kiguchi K, Rho O, DiGiovanni D. Development of a transgenic mouse model to determine the role of IGF-I in epithelial carcinogenesis. Abstract. Proceedings of the American Association for Cancer Research 37:534,1996.